Importer of Controlled Substances; Notice of Application, 55583-55584 [E9-25905]
Download as PDF
<![CDATA[
55583
Federal Register / Vol. 74, No. 207 / Wednesday, October 28, 2009 / Notices
In light of these circumstances, the
Commission has determined as follows:
(a) The public may submit comments on
remedy, the public interest, and
bonding until November 2, 2009. (b)
The parties and the public may reply to
any submissions on remedy, the public
interest, and bonding until November 9,
2009. (c) The parties’ schedule for
briefing on any issues related to
violation is unaffected by this extension.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and under sections 210.50 of the
Commission’s Rules of Practice and
Procedure (19 CFR 210.50).
Issued: October 23, 2009.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E9–26019 Filed 10–27–09; 8:45 am]
Commerce on or before November 17,
2009.)
6. Inv. Nos. 701–TA–473 and 731–
TA–1173 (Preliminary) (Certain Sodium
and Potassium Phosphate Salts from
China)—briefing and vote. (The
Commission is currently scheduled to
transmit its determinations to the
Secretary of Commerce on or before
November 9, 2009; Commissioners’
opinions are currently scheduled to be
transmitted to the Secretary of
Commerce on or before November 17,
2009.)
7. Outstanding action jackets: none.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
BILLING CODE 7020–02–P
By order of the Commission.
Issued: October 26, 2009.
William R. Bishop,
Hearings and Meetings Coordinator.
[FR Doc. E9–26104 Filed 10–26–09; 4:15 pm]
INTERNATIONAL TRADE
COMMISSION
BILLING CODE 7020–02–P
[USITC SE–09–029]
DEPARTMENT OF JUSTICE
erowe on DSK5CLS3C1PROD with NOTICES
Government in the Sunshine Act
Meeting Notice
Drug Enforcement Administration
AGENCY HOLDING THE MEETING: United
States International Trade Commission.
TIME AND DATE: November 6, 2009 at 11
a.m.
PLACE: Room 101, 500 E Street, SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agenda for future meetings: none.
2. Minutes.
3. Ratification List.
4. Inv. Nos. 701–TA–470–471 and
731–TA–1169–1170 (Preliminary)
(Certain Coated Paper Suitable for HighQuality Print Graphics Using Sheet-Fed
Presses from China and Indonesia)—
briefing and vote. (The Commission is
currently scheduled to transmit its
determinations to the Secretary of
Commerce on or before November 9,
2009; Commissioners’ opinions are
currently scheduled to be transmitted to
the Secretary of Commerce on or before
November 17, 2009.)
5. Inv. Nos. 701–TA–472 and 731–
TA–1171–1172 (Preliminary) (Certain
Standard Steel Fasteners from China
and Taiwan)—briefing and vote. (The
Commission is currently scheduled to
transmit its determinations to the
Secretary of Commerce on or before
November 9, 2009; Commissioners’
opinions are currently scheduled to be
transmitted to the Secretary of
VerDate Nov<24>2008
15:34 Oct 27, 2009
Jkt 220001
Importer of Controlled Substances
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with Title 21
Code of Federal Regulations (CFR),
1301.34(a), this is notice that on August
27, 2009, Formulation Technologies
LLC., 11400 Burnet Road, Suite 4010,
Austin, Texas 78758, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Fentanyl (9801), a basic
class of controlled substance listed in
schedule II.
The company plans to import the
listed controlled substance for analytical
characterization, secondary packaging,
and for distribution to clinical trial sites.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic class of controlled substance
may file comments or objections to the
issuance of the proposed registration
and may, at the same time, file a written
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
request for a hearing on such
application pursuant to 21 CFR 1301.43
and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections
being sent via regular mail should be
addressed, in quintuplicate, to the Drug
Enforcement Administration, Office of
Diversion Control, Federal Register
Representative (ODL), 8701 Morrissette
Drive, Springfield, Virginia 22152; and
must be filed no later than November
27, 2009.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substances in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: October 20, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–25862 Filed 10–27–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
This is notice that on July 9, 2009,
Cody Laboratories Inc., 601 Yellowstone
Avenue, Cody, Wyoming 82414–9321,
made application by renewal to the
Drug Enforcement Administration
(DEA) for registration as an importer of
the basic classes of controlled
substances listed in schedule II:
Drug
Raw Opium (9600) .......................
Concentrate of Poppy Straw
(9670).
Schedule
II
II
The company plans to import narcotic
raw materials for manufacturing and
further distribution to its customers.
The company is registered with DEA as
a manufacturer of several controlled
substances that are manufactured from
raw opium, poppy straw, and
concentrate of poppy straw.
E:\FR\FM\28OCN1.SGM
28OCN1
55584
Federal Register / Vol. 74, No. 207 / Wednesday, October 28, 2009 / Notices
As explained in the Correction to
Notice of Application pertaining to
Rhodes Technologies, 72 FR 3417
(2007), comments and requests for
hearings on applications to import
narcotic raw material are not
appropriate.
As noted in a previous notice
published in the Federal Register on
September 23, 1975, (40 FR 43745), all
applicants for registration to import a
basic class of any controlled substances
in schedule I or II are, and will continue
to be, required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b),(c),(d),(e), and (f) are
satisfied.
Dated: October 20, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–25905 Filed 10–27–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
erowe on DSK5CLS3C1PROD with NOTICES
Importer of Controlled Substances;
Notice of Application
This is notice that on September 18,
2009, Clinical Supplies Management,
342 42nd Street South, Fargo, North
Dakota 58103, made application to the
Drug Enforcement Administration
(DEA) for registration as an importer of
Poppy Straw Concentrate (9670), a basic
class of controlled substance listed in
schedule II.
The company plans to import an
ointment for the treatment of wounds
which contains trace amounts of
controlled substances normally found in
poppy straw concentrate which will be
packaged and labeled for clinical trials.
As explained in the Correction to
Notice of Application pertaining to
Rhodes Technologies, 72 FR 3417
(2007), comments and requests for
hearings on applications to import
narcotic raw material are not
appropriate.
As noted in a previous notice
published in the Federal Register on
September 23, 1975, (40 FR 43745), all
applicants for registration to import a
basic class of any controlled substances
in schedule I or II are, and will continue
to be, required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
VerDate Nov<24>2008
15:34 Oct 27, 2009
Jkt 220001
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b),(c),(d),(e), and (f) are
satisfied.
Dated: October 16, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–25903 Filed 10–27–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on
September 16, 2009, Hospira Inc., 1776
North Centennial Drive, McPherson,
Kansas 67460–1247, made application
to the Drug Enforcement Administration
(DEA) to be registered as an importer of
Remifentanil (9739), a basic class of
controlled substance listed in schedule
II.
The company plans to import
Remifentanil for use in dosage form
manufacturing.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic class of controlled substance
may file comments or objections to the
issuance of the proposed registration
and may, at the same time, file a written
request for a hearing on such
application pursuant to 21 CFR 1301.43
and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than November 27, 2009.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
(40 FR 43745), all applicants for
registration to import a basic class of
any controlled substance in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: October 21, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–26000 Filed 10–27–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with Title 21
Code of Federal Regulations (CFR),
1301.34(a), this is notice that on
September 4, 2009, Cerilliant
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78665–2402, made
application via the Internet to the Drug
Enforcement Administration (DEA) to
be registered as an importer of 5Methoxy-N,N-diisopropyltryptamine
(7439), a basic class of controlled
substance listed in schedule I.
The company plans to import small
quantities of the listed controlled
substance for the manufacture of
analytical reference standards.
Any bulk manufacturers who are
presently, or are applying to be,
registered with DEA to manufacture
such basic class of controlled substance
may file comments or objections to the
issuance of the proposed registration
and may, at the same time, file a written
request for a hearing on such
application pursuant to 21 CFR 1301.43
and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
E:\FR\FM\28OCN1.SGM
28OCN1
]]>Agencies
[Federal Register Volume 74, Number 207 (Wednesday, October 28, 2009)]
[Notices]
[Pages 55583-55584]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-25905]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
This is notice that on July 9, 2009, Cody Laboratories Inc., 601
Yellowstone Avenue, Cody, Wyoming 82414-9321, made application by
renewal to the Drug Enforcement Administration (DEA) for registration
as an importer of the basic classes of controlled substances listed in
schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Raw Opium (9600)............................ II
Concentrate of Poppy Straw (9670)........... II
------------------------------------------------------------------------
The company plans to import narcotic raw materials for
manufacturing and further distribution to its customers. The company is
registered with DEA as a manufacturer of several controlled substances
that are manufactured from raw opium, poppy straw, and concentrate of
poppy straw.
[[Page 55584]]
As explained in the Correction to Notice of Application pertaining
to Rhodes Technologies, 72 FR 3417 (2007), comments and requests for
hearings on applications to import narcotic raw material are not
appropriate.
As noted in a previous notice published in the Federal Register on
September 23, 1975, (40 FR 43745), all applicants for registration to
import a basic class of any controlled substances in schedule I or II
are, and will continue to be, required to demonstrate to the Deputy
Assistant Administrator, Office of Diversion Control, Drug Enforcement
Administration, that the requirements for such registration pursuant to
21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b),(c),(d),(e),
and (f) are satisfied.
Dated: October 20, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-25905 Filed 10-27-09; 8:45 am]
BILLING CODE 4410-09-P
